Dynocardia, Inc
Dynocardia is a pioneering medical technology company focused on developing innovative solutions for continuous and accurate blood pressure monitoring. Their flagship platform, ViTrack, is a cuff-less, wearable device that employs proprietary optomechanical sensors and computer vision to provide real-time, non-invasive blood pressure and hemodynamic measurements. With applications spanning hospital, clinical, remote, and wellness markets, Dynocardia aims to revolutionize healthcare by enabling continuous, precise, and non-invasive monitoring of vital signs, thereby improving patient outcomes and clinical decision-making.
Industries
Nr. of Employees
small (1-50)
Dynocardia, Inc
One Broadway, CIC, Cambridge, MA 02142
Patents
Spatiotemporal-based detection and correction of motion artifact for measurement of arterial pressure waveform
US-12599340-B2
View Details
Spatiotemporal-based detection and correction of motion artifact for measurement of arterial pressure waveform
US-12599340-B2
View DetailsProducts
Wrist-worn cuff-less continuous blood pressure monitoring device
Wearable platform that provides continuous, non-invasive beat-to-beat blood pressure and derived hemodynamic parameters using an optomechanical sensor array and algorithmic motion correction; designed for hospital and remote monitoring contexts.
Wrist-worn cuff-less continuous blood pressure monitoring device
Wearable platform that provides continuous, non-invasive beat-to-beat blood pressure and derived hemodynamic parameters using an optomechanical sensor array and algorithmic motion correction; designed for hospital and remote monitoring contexts.
Services
Design and execution of clinical studies evaluating continuous non-invasive BP and hemodynamic monitoring across ICU and outpatient settings, including multi-site collaborations.
Development of signal processing, image processing, machine learning algorithms and real-time embedded software for physiological monitoring devices, including V&V support and documentation.
Mechanical design, small-scale prototyping, sensor integration, and hands-on test setup support for wearable medical devices; coordination with contract manufacturers for component production.
Collaboration opportunities with manufacturing firms, specialty technology providers, and distribution channels to accelerate late-stage development and market entry of continuous BP monitoring solutions.
Design and execution of clinical studies evaluating continuous non-invasive BP and hemodynamic monitoring across ICU and outpatient settings, including multi-site collaborations.
Development of signal processing, image processing, machine learning algorithms and real-time embedded software for physiological monitoring devices, including V&V support and documentation.
Mechanical design, small-scale prototyping, sensor integration, and hands-on test setup support for wearable medical devices; coordination with contract manufacturers for component production.
Collaboration opportunities with manufacturing firms, specialty technology providers, and distribution channels to accelerate late-stage development and market entry of continuous BP monitoring solutions.
Expertise Areas
- Continuous blood pressure monitoring (cNIBP)
- Medical device R&D for patient monitoring
- Optical and tactile sensor development
- Signal processing and machine learning for physiological signals
Key Technologies
- Optomechanical tactile sensing
- Computer vision for motion correction
- Machine learning / deep learning
- Signal and image processing
News & Updates
Dynocardia received a $1 million grant from the National Science Foundation to enhance its computer vision-based motion-artifact mitigation technology, accelerating the development of ViTrack for diverse environments.
The NIH awarded Dynocardia a $500,000 grant to support the commercialization of ViTrack, a wrist-worn device for accurate, continuous blood pressure monitoring.
Dynocardia's ViTrack Technology Receives NIH and NSF Grants
Dynocardia has secured significant funding from NIH and NSF to develop and validate its innovative cuff-less blood pressure monitoring platform, ViTrack.
Dynocardia Wins HRX 2023 Breakthrough Innovation Award
The company was awarded for its groundbreaking digital health solution in cardiovascular health, highlighting its impact on the industry.
HRX 2023 Breakthrough Innovation Award in Cardiovascular Health
Dynocardia received this award for its innovative blood pressure monitoring technology, ViTrack.
NIH and NSF Grants for Technological Advancement
Secured grants to support the development and clinical validation of ViTrack platform.
Dynocardia received a $1 million grant from the National Science Foundation to enhance its computer vision-based motion-artifact mitigation technology, accelerating the development of ViTrack for diverse environments.
The NIH awarded Dynocardia a $500,000 grant to support the commercialization of ViTrack, a wrist-worn device for accurate, continuous blood pressure monitoring.
Dynocardia's ViTrack Technology Receives NIH and NSF Grants
Dynocardia has secured significant funding from NIH and NSF to develop and validate its innovative cuff-less blood pressure monitoring platform, ViTrack.
Dynocardia Wins HRX 2023 Breakthrough Innovation Award
The company was awarded for its groundbreaking digital health solution in cardiovascular health, highlighting its impact on the industry.
HRX 2023 Breakthrough Innovation Award in Cardiovascular Health
Dynocardia received this award for its innovative blood pressure monitoring technology, ViTrack.
NIH and NSF Grants for Technological Advancement
Secured grants to support the development and clinical validation of ViTrack platform.